Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with prostate cancer that has grown beyond the outer layer of the prostate (known as T3a or more advanced stage)
- People whose PSA level (a protein measured in the blood related to prostate health) is above 20
- People whose cancer has been graded as a Gleason score of 8 or higher (a measure of how aggressive the cancer cells look under a microscope)
- People who are generally able to carry out daily activities with only minor difficulty, as measured by a standard health scoring tool (Karnofsky score of 70 or above)
- People who have signed the trial's specific consent form agreeing to take part
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 514-340-8222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with biochemical failure showing coexistence of PTEN and TMPRSS2-ERG gene fusion.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.